Dose-levels and first signs of efficacy in contemporary oncology phase 1 clinical trials.

<h4>Purpose</h4>Phase 1 trials play a crucial role in oncology by translating laboratory science into efficient therapies. Molecular targeted agents (MTA) differ from traditional cytotoxics in terms of both efficacy and toxicity profiles. Recent reports suggest that higher doses are not...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Charles Ferte, Jean-Charles Soria, Nicolas Penel
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5a2a81cdc79344aebd66a927e68dc8c6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!